{"id":"https://openalex.org/W2015921111","doi":"https://doi.org/10.1016/s1043-321x(07)80110-x","title":"4\u20134 p95HER-2 Predicts Worse Outcome in Patients With HER-2-Positive Breast Cancer","display_name":"4\u20134 p95HER-2 Predicts Worse Outcome in Patients With HER-2-Positive Breast Cancer","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W2015921111","doi":"https://doi.org/10.1016/s1043-321x(07)80110-x","mag":"2015921111"},"language":"en","primary_location":{"id":"doi:10.1016/s1043-321x(07)80110-x","doi":"https://doi.org/10.1016/s1043-321x(07)80110-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1043-321x(07)80110-x","pdf_url":null,"source":{"id":"https://openalex.org/S2764352954","display_name":"Breast Diseases A Year Book Quarterly","issn_l":"1043-321X","issn":["1043-321X","1878-1918"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Diseases: A Year Book Quarterly","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013400628","display_name":"Ann D. Thor","orcid":"https://orcid.org/0000-0001-7725-1869","observed_orcids":["https://orcid.org/0000-0001-7725-1869"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"A.D. Thor","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5013400628"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1673,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.59419669,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"17","issue":"4","first_page":"336","last_page":"336"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.7369999885559082},{"id":"https://openalex.org/keywords/p95her2","display_name":"p95HER2","score":0.9100000262260437},{"id":"https://openalex.org/keywords/her2-receptor","display_name":"HER2 receptor","score":0.3479999899864197},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8880000114440918},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8364279270172119},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7693252563476562},{"id":"https://openalex.org/C148220186","wikidata":"https://www.wikidata.org/wiki/Q7111912","display_name":"Outcome (game theory)","level":2,"score":0.6904812455177307},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6105079054832458},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5424647331237793},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.39692896604537964},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.03411209583282471},{"id":"https://openalex.org/C144237770","wikidata":"https://www.wikidata.org/wiki/Q747534","display_name":"Mathematical economics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1043-321x(07)80110-x","doi":"https://doi.org/10.1016/s1043-321x(07)80110-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1043-321x(07)80110-x","pdf_url":null,"source":{"id":"https://openalex.org/S2764352954","display_name":"Breast Diseases A Year Book Quarterly","issn_l":"1043-321X","issn":["1043-321X","1878-1918"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Diseases: A Year Book Quarterly","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2004523602","https://openalex.org/W2062211344","https://openalex.org/W2033658137","https://openalex.org/W2904774628","https://openalex.org/W2020000084","https://openalex.org/W2023681515","https://openalex.org/W1987760016","https://openalex.org/W2911732890","https://openalex.org/W4415939920","https://openalex.org/W2026514817"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2016-06-24T00:00:00"}